Financials data is unavailable for this security.
View more
Year on year Dexcom Inc grew revenues 24.49% from 2.91bn to 3.62bn while net income improved 58.70% from 341.20m to 541.50m.
Gross margin | 63.16% |
---|---|
Net profit margin | 16.95% |
Operating margin | 17.32% |
Return on assets | 9.79% |
---|---|
Return on equity | 29.41% |
Return on investment | 13.57% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Dexcom Inc fell by 75.80m. However, the company earned 748.50m from its operations for a Cash Flow Margin of 20.66%. In addition the company used 507.20m on investing activities and also paid 318.60m in financing cash flows.
Cash flow per share | 2.08 |
---|---|
Price/Cash flow per share | 33.04 |
Book value per share | 6.08 |
---|---|
Tangible book value per share | 5.73 |
More ▼
Balance sheet in USDView more
Current ratio | 2.82 |
---|---|
Quick ratio | 2.48 |
Total debt/total equity | 1.03 |
---|---|
Total debt/total capital | 0.5063 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 90.11 |